SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001753926-24-000309
Filing Date
2024-02-14
Accepted
2024-02-14 20:47:28
Documents
1
Group Members
BRENDAN O'NEILIONIC MANAGEMENT, LLCKEITH COULSTON

Document Format Files

Seq Description Document Type Size
1 SC 13G/A g084059_sch13ga.htm SC 13G/A 67826
  Complete submission text file 0001753926-24-000309.txt   69633
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Subject) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89366 | Film No.: 24641697
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3053 FILLMORE ST. SUITE 256 SAN FRANCISCO CA 94123
Business Address 3053 FILLMORE ST. SUITE 256 SAN FRANCISCO CA 94123 415-999-2132
Ionic Ventures, LLC (Filed by) CIK: 0001769419 (see all company filings)

IRS No.: 660889836 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A